Literature DB >> 12810338

The Washington Psychosocial Seizure Inventory (WPSI): psychometric evaluation and future applications.

Chih-Hung Chang1, Sarah Gehlert.   

Abstract

The Washington Psychosocial Seizure Inventory (WPSI) clinical scales were developed via an empirical item selection approach and have been used widely to measure aspects of psychosocial functioning of patients with epilepsy. However, these empirically derived clinical scales have not been assessed psychometrically using a modern item response theory-based model. The goals of this study were to: (1) evaluate how items in each clinical scale performed in such a way as to represent the underlying constructs being measured; and (2) derive a shorter version while maintaining measurement precision. WPSI item response data from 145 adults with epilepsy collected for an evaluation study of an intervention to pact negative attributional style in epilepsy were used. The dichotomous Rasch model suitable for the true-false response choices was used to analyse each clinical scale separately. Most items within each scale fit the measurement model well, with very few exceptions. All items, therefore, were retained. A method, based on computerised adaptive testing (CAT), is offered for shortening the WPSI using a psychosocial outcomes item bank derived from the study. Individuals' specific levels of functioning are used to derive measures of their psychosocial functioning with a minimum number of items.

Entities:  

Mesh:

Year:  2003        PMID: 12810338     DOI: 10.1016/s1059-1311(02)00275-3

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  3 in total

1.  Relative precision, efficiency and construct validity of different starting and stopping rules for a computerized adaptive test: the GAIN substance problem scale.

Authors:  Barth B Riley; Kendon J Conrad; Nikolaus Bezruczko; Michael L Dennis
Journal:  J Appl Meas       Date:  2007

Review 2.  Patient Reported Outcome (PRO) assessment in epilepsy: a review of epilepsy-specific PROs according to the Food and Drug Administration (FDA) regulatory requirements.

Authors:  Annabel Nixon; Cicely Kerr; Katie Breheny; Diane Wild
Journal:  Health Qual Life Outcomes       Date:  2013-03-11       Impact factor: 3.186

3.  Evaluation of the Functional Assessment of Cancer Therapy-General (FACT-G) Spanish Version 4 in South America: classic psychometric and item response theory analyses.

Authors:  Juan J Dapueto; Carla Francolino; Liliana Servente; Chih-Hung Chang; Irene Gotta; Roberto Levin; María Del Carmen Abreu
Journal:  Health Qual Life Outcomes       Date:  2003-08-20       Impact factor: 3.186

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.